| USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES |
USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES |
95%
|
USAspending awards from Department of Health and Human Services: $74,026,005 across 5 awards. 75D30122C13699 COVID 19 GENOMIC SEQUENCING; 75D30121C10058 SEROLOGY TESTING SERVICES; 75P00120C00026 COVI… |
| USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS |
USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS |
95%
|
USAspending awards from Department of Veterans Affairs: $33,904,933 across 5 awards. 36C24725N0388 TASK ORDER FOR REF LAB BRIDGE WHILE SOLIITATION IS CURRENTLY ACTIVE TO AVOID SERVICE DISRUPTION.; 36… |
| CLIENT-PAYERS |
CLIENT-PAYERS |
90%
|
These estimates include the impact of contractual allowances (including payer denials), and patient price concessions. The portfolios determined using the portfolio approach consist of the following … |
| GOVERNMENT-PAYERS |
GOVERNMENT-PAYERS |
90%
|
These estimates include the impact of contractual allowances (including payer denials), and patient price concessions. The portfolios determined using the portfolio approach consist of the following … |
| HEALTHCARE-INSURERS |
HEALTHCARE-INSURERS |
90%
|
These estimates include the impact of contractual allowances (including payer denials), and patient price concessions. The portfolios determined using the portfolio approach consist of the following … |
| HOSPITALS |
HOSPITALS |
90%
|
The DIS business provides diagnostic information services to a broad range of customers within its primary customer channels - physicians, hospitals, and patients and consumers. |
| PAYERS |
PAYERS |
90%
|
The Company's DS businesses offer solutions for insurers and offer solutions for healthcare providers and payers. |
| PHYSICIANS |
PHYSICIANS |
90%
|
The DIS business provides diagnostic information services to a broad range of customers within its primary customer channels - physicians, hospitals, and patients and consumers. |
| FLGT |
Fulgent Genetics, Inc. |
72%
|
Reciprocal relationship from FLGT graph: , information technology, and service companies may develop and sell competitive tests, which may include informatics analysis, integrated genetic tools, and … |
| PRPH |
ProPhase Labs, Inc. |
72%
|
Reciprocal relationship from PRPH graph: avorable interpretation of EKRA for laboratory compensation structures, we cannot be assured that courts in our jurisdiction will reach the same conclusion or… |
| DESCRIPTION-OF-BUSINESS-BACKGROUND-QUEST-DIAGNOS |
DESCRIPTION-OF-BUSINESS-BACKGROUND-QUEST-DIAGNOS |
62%
|
indicated) 1. DESCRIPTION OF BUSINESS Background Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") work across the healthcare ecosystem to create a healthier … |
| HAYSTACK-ONCOLOGY-INC |
HAYSTACK-ONCOLOGY-INC |
62%
|
ented by the growth of consumer-initiated testing and demand for expanded access to basic healthcare services. In 2024, we launched a new service that offers patients experiencing symptoms of several… |
| LENCO-DIAGNOSTIC-LABORATORIES-INC |
LENCO-DIAGNOSTIC-LABORATORIES-INC |
62%
|
the delivery of healthcare services. Clinical testing is used for predisposition, screening, monitoring, diagnosis, prognosis and treatment choices of diseases and other medical conditions. We primar… |
| OPTUM360-LLC |
OPTUM360-LLC |
62%
|
2021, the court denied the Company's motion to dismiss the complaint. After discovery was completed, the Company's filed a motion for summary judgment, which was granted. The matter is on appeal. On … |
| RETRIEVAL-MASTERS-CREDITORS-BUREAU-INC |
RETRIEVAL-MASTERS-CREDITORS-BUREAU-INC |
62%
|
rface, store or process confidential patient and employee data or other confidential information, as well as those third parties’ providers, are also subject to the risks outlined above. For example,… |
